Lv1
30 积分 2023-09-17 加入
The changing landscape of HIV-associated kidney disease
13天前
已完结
Chronic Tonsillitis and IgA Nephropathy: Findings From a Nationwide Japanese Cohort Study
15天前
已完结
The Treatment of Primary IgA Nephropathy: Change, Change, Change
15天前
已完结
A new alternative: inhibiting complement activation in patients with IgA nephropathy
16天前
已完结
Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
16天前
已完结
Application of the updated International IgA Nephropathy Prediction Tool in children one- or two-years post-biopsy
16天前
已完结
Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy
16天前
已完结
The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy
16天前
已完结
A Phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
16天前
已完结
Galectin-3 contributes to pathogenesis of IgA nephropathy
18天前
已完结
皖公网安备34019202002308
